Our portfolio addresses four critical unmet needs in male health.
TestiMax
Male enhancement is a global market with strong demand but limited safe options. Current approaches are invasive or unsafe. Confidence and self-image drive well-being and relationships.
TestiMax offers a safe, natural, progressive scrotal enlargement solution — without surgery or irreversible procedures.
Using a proprietary, non-invasive process, TestiMax increases scrotal volume gradually, ensuring safety, comfort, and reversibility.
SpermaBlock
Over 70% of contraceptive responsibility is borne by women. Men face few options: condoms, vasectomy (irreversible), or hormonal pills with side effects. In Europe, less than 2% of men undergo vasectomy; in the U.S., only ~6%.
SpermaBlock is a revolutionary non-hormonal, reversible male contraceptive.
A breakthrough technology acts as a temporary barrier, safely preventing sperm release while preserving reversibility. No hormones, no systemic effects, no surgery.
SpermaBlock is a revolutionary non-hormonal, reversible male contraceptive.
A breakthrough technology acts as a temporary barrier, safely preventing sperm release while preserving reversibility. No hormones, no systemic effects, no surgery.
RigiPen
Erectile dysfunction (ED) affects >50% of men over 50. The global ED treatment market exceeds $3 billion annually, dominated by oral drugs with side effects. Many men seek safer, on-demand alternatives.
RigiPen is a next-generation, drug-free solution for restoring erectile function naturally.
Leveraging biomedical innovation, RigiPen provides safe, effective support for erectile rigidity, without systemic risks or invasive procedures.
RigiPen is a next-generation, drug-free solution for restoring erectile function naturally.
Leveraging biomedical innovation, RigiPen provides safe, effective support for erectile rigidity, without systemic risks or invasive procedures.
DiagnoStick
1 in 7 couples struggles with infertility, yet male health diagnostics remain limited to outdated sperm analysis. Meanwhile, wearable tech (e.g., smartwatches) fails to capture reproductive health markers.
DiagnoStick is the world’s first comprehensive male health monitoring device, offering fertility, hormonal, and wellness tracking.
Powered by biocensors and AI, DiagnoStick delivers real-time data far beyond today’s consumer wearables. It empowers men to take control of their reproductive and overall health.
DiagnoStick is the world’s first comprehensive male health monitoring device, offering fertility, hormonal, and wellness tracking.
Powered by biocensors and AI, DiagnoStick delivers real-time data far beyond today’s consumer wearables. It empowers men to take control of their reproductive and overall health.